Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Pfizer's Earnings Are Outstanding
Motley Fool
Wednesday, September 14, 2011 - 11:37am
tags:
Pfizer, earnings
Daiichi Unit Warned By FDA Over Manufacturing
Pharmalot
Wednesday, September 14, 2011 - 11:14am
tags:
FDA, warnings, Daiichi Sankyo, Luitpold, drug manufacturing
Boston Scientific taps J&J exec as its next CEO
Reuters
Wednesday, September 14, 2011 - 11:12am
tags:
JNJ, Boston Scientific, Michael Mahoney
Naming Names: Lawmakers Tighten the Screws on Pharmaceutical Marketing
Forbes
Wednesday, September 14, 2011 - 11:09am
tags:
physician payments
Four Biotech Picks to Fight Hepatitis C
Barron's
Wednesday, September 14, 2011 - 11:07am
tags:
hepatitis C, Achillion, Pharmasset, Inhibitex, Medivir, Vertex, JNJ
6 Deeply Undervalued Biotech Companies
Seeking Alpha
Wednesday, September 14, 2011 - 11:03am
tags:
Amgen, Biogen Idec, Bristol-Myers Squibb, Dendreon, Gilead, GSK, Oncothyreon, JNJ, Novartis, Sanofi, UBS, Vanda
Drug Launches: It's All About Expectations
Motley Fool
Wednesday, September 14, 2011 - 11:00am
tags:
drug launches, Optimer, Dificid, Dendreon, Provenge, Vancocin, ViroPharma, Cubist Pharmaceuticals
Will Biogen Idec Disappoint Analysts Next Quarter?
Motley Fool
Wednesday, September 14, 2011 - 10:58am
tags:
Biogen Idec, analysts
Medicis sells fat-buster technology to Solta Medical for $35M
Bizjournals.com
Wednesday, September 14, 2011 - 10:55am
tags:
Solta Medical, Medicis, Liposonix
InterMune tumbles 9% on stock offering
Marketwatch
Wednesday, September 14, 2011 - 10:53am
tags:
InterMune, stock offering
Banking on Botox no concern for Allergan CEO
Reuters
Wednesday, September 14, 2011 - 10:51am
tags:
Botox, Allergan, Pharma CEOs, David Pyott, JNJ
Teva investing $19M in CureTech, aiding in R&D
Yahoo/AP
Wednesday, September 14, 2011 - 10:46am
tags:
Teva Pharmaceuticals, R&D, CureTech
Merck Sticks With The Partnership Model In China For R&D
Seeking Alpha
Wednesday, September 14, 2011 - 10:44am
tags:
Merck, R&D, China
Pfizer Delays Formula Unit Sale to Explore Spinoff
Bloomberg
Wednesday, September 14, 2011 - 10:23am
tags:
Pfizer, infant formula, M&A, Danone SA, Abbott Laboratories, Nestle
Lilly invests $30M in chronic-disease partnerships
Yahoo/AP
Wednesday, September 14, 2011 - 10:22am
tags:
Eli Lilly, Brazil, Mexico, South Africa
Johnson & Johnson Gets CRL on Simponi
Yahoo/Zacks.com
Wednesday, September 14, 2011 - 10:21am
tags:
JNJ, Simponi, Merck, psoriatic arthritis
Abbott Laboratories is Dealing to Flank Other Drug Makers
Yahoo/Wall St. Cheat Sheet
Wednesday, September 14, 2011 - 10:19am
tags:
Abbott Laboratories, Amgen, Bristol-Myers Squibb
Novartis Drug Cleared in EU for SEGA
Yahoo/Zacks.com
Wednesday, September 14, 2011 - 10:17am
tags:
Novartis, Europe, subependymal giant cell astrocytomas, SEGA, Pfizer, ONYX Pharmaceuticals
Is Abbott Laboratories' Cash Machine Slowing Down?
Motley Fool
Wednesday, September 14, 2011 - 10:16am
tags:
Abbott Laboratories
New PDUFA Changes FDA Panels: Mike Explains
Pharmalot
Tuesday, September 13, 2011 - 2:24pm
tags:
FDA, PDUFA, advisory panels

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.